All In Biotech

Drug Trial Radar · NCT03341078

Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users

Brain Function and Connectivity in Methamphetamine Dependence: The Link to Neuroinflammation and the Effects of Ibudilast

Last checked: Nov 19, 2026Latest source record: Feb 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 176 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

176

Actual

Start

May 1, 2019

Primary completion

Oct 15, 2025

Study completion Oct 15, 2025

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
Collaborators
Portland VA Medical Center; Oregon Health and Science University
First posted
Nov 14, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Addiction to methamphetamine is a serious health problem in the United States. Right now, there are no medications that a doctor can give someone to help them stop using methamphetamine. More research is needed to develop drugs for methamphetamine addiction. Ibudilast (the study drug) is a drug that could help people addicted to methamphetamine.

Conditions

  • Methamphetamine-dependence

Interventions

  • IbudilastDrug

    Ibudilast capsules will be orally ingested twice daily for 6 weeks.

  • Placebo Oral TabletDrug

    Placebo capsules will be orally ingested twice daily for 6 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effects of ibudilast on brain function as assessed by magnetic resonance imaging (MRI)Time frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • VA Portland Health Care System, Portland, OR

    Portland, Oregon

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.